Northern Trust Corp Dice Therapeutics, Inc. Transaction History

Northern Trust Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$25.86 - $46.71 $963,647 - $1.74 Million	37,264 Added 12.06%	346,261 $16.1 Million
Q1 2023 May 15, 2023	SELL	$26.05 - $32.31 $3,647 - $4,523	-140 Reduced 0.05%	308,997 $8.85 Million
Q4 2022 Feb 13, 2023	BUY	$19.77 - $42.23 $1.56 Million - $3.32 Million	78,657 Added 34.13%	309,137 $9.65 Million
Q3 2022 Nov 14, 2022	BUY	$14.97 - $22.65 $259,983 - $393,362	17,367 Added 8.15%	230,480 $4.67 Million
Q2 2022 Aug 12, 2022	BUY	$13.19 - $22.1 $1.24 Million - $2.08 Million	93,893 Added 78.76%	213,113 $3.31 Million
Q1 2022 May 13, 2022	SELL	$14.54 - $25.02 $80,667 - $138,810	-5,548 Reduced 4.45%	119,220 $2.28 Million
Q4 2021 Feb 08, 2022	BUY	$22.41 - $37.54 $2.8 Million - $4.68 Million	124,768 New	124,768 $3.16 Million

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.